Atogepant

ATC N02CD07 · 10 markets · 22 records

Atogepant 10 markets · 22 records Forms

US 3 records · 3 strengths

60 mgtabletQulipta also in CA·AU·GB +3
10 mgtabletQulipta also in CA·AU·GB +3
30 mgtabletQulipta also in CA·AU

CA 3 records · 3 strengths

60 mgtabletQulipta also in US·AU·GB +3
10 mgtabletQulipta also in US·AU·GB +3
30 mgtabletQulipta also in US·AU

AU 3 records · 3 strengths

60 mgtabletAQUIPTA atogepant 10 mg tablet blister pack also in US·CA·GB +3 unknown
10 mgtabletAQUIPTA atogepant 10 mg tablet blister pack also in US·CA·GB +3 unknown
30 mgtabletAQUIPTA atogepant 10 mg tablet blister pack also in US·CA unknown

GB 2 records · 2 strengths

60 mgtabletAquipta 60mg tablets also in US·CA·AU +3
10 mgtabletAquipta 60mg tablets also in US·CA·AU +3

SG 2 records · 2 strengths

60 mgtabletAquipta 60mg tablets also in US·CA·AU +3
10 mgtabletAquipta 60mg tablets also in US·CA·AU +3

ES 2 records · 2 strengths

60 mgtabletAquipta 60mg tablets also in US·CA·AU +3
10 mgtabletAquipta 60mg tablets also in US·CA·AU +3

TW 2 records · 2 strengths

60 mgtabletAquipta 60mg tablets+1艾妥達錠60毫克 also in US·CA·AU +3
10 mgtabletAquipta 60mg tablets+1艾妥達錠10毫克 also in US·CA·AU +3

HK 2 records · 1 strengths

Records without a stated strength · 1 Aquipta 60mg tablets

MX 1 records · 1 strengths

Records without a stated strength · 1 Aquipta 60mg tablets

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Aquipta 60mg tablets

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	TW	HK	EU
60 mg tablet	Qulipta	Aquipta 60mg tablets	Qulipta	AQUIPTA atogepant 10 mg tablet blister pack	Aquipta 60mg tablets	Aquipta 60mg tablets	not recorded	Aquipta 60mg tablets 艾妥達錠60毫克	not recorded	not recorded
10 mg tablet	Qulipta	Aquipta 60mg tablets	Qulipta	AQUIPTA atogepant 10 mg tablet blister pack	Aquipta 60mg tablets	Aquipta 60mg tablets	not recorded	Aquipta 60mg tablets 艾妥達錠10毫克	not recorded	not recorded
30 mg tablet	Qulipta	not recorded	Qulipta	AQUIPTA atogepant 10 mg tablet blister pack	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Aquipta 60mg tablets	Aquipta 60mg tablets
not disclosed tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Aquipta 60mg tablets	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in MX · HK · EU and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en MX · HK · EU que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 MX · HK · EU 有记录（未在本表显示）。另有 2 個規格/劑型僅在 MX · HK · EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.